APO Research
Talk to an analyst

APO RESEARCH · REPORT

Universal Nuclease

Compare research editions
View pricing & licenses

Selected research

Industry Research

Universal Nuclease Industry Research Report 2026

8 January 2026146 pages

Choose your research edition.

Industry ResearchUniversal Nuclease Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Universal Nuclease Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Universal Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Universal Nuclease Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Universal Nuclease Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Universal Nuclease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Universal Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Universal Nuclease is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Universal Nuclease is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Universal Nuclease include Merck, Thermo Fisher Scientific Inc., New England Biolabs, Bio-Techne Corporation, GenScript, AMSBIO, ACROBiosystems Group, Nanjing Vazyme Biotech Co., Ltd. and Sino Biological,Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Universal Nuclease market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Universal Nuclease Market by Company

Merck

Thermo Fisher Scientific Inc.

New England Biolabs

Bio-Techne Corporation

GenScript

AMSBIO

ACROBiosystems Group

Nanjing Vazyme Biotech Co., Ltd.

Sino Biological,Inc.

ProteoGenix

Novoprotein Scientific Inc.

TransGen Biotech

Enzynomics

Yisheng Biotechnology (Shanghai) Co., Ltd.

ProSpec

KACTUS

Shanghai Biyuntian Biotechnology Co., Ltd.

RayBiotech, Inc.

Wuhan Hzymes Biotechnology Co., Ltd.

Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.

Universal Nuclease Segment by Type

GMP

Scientific Research

Universal Nuclease Segment by Application

Medical Biology

Laboratory

Others

Universal Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Universal Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Universal Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Universal Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Universal Nuclease manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Universal Nuclease by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Universal Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Universal Nuclease Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Universal Nuclease Sales (k units) of Manufacturers (2021-2026) Table 7. Global Universal Nuclease Sales Market Share by Manufacturers (2021-2026) Table 8. Global Universal Nuclease Revenue of Manufacturers (2021-2026) Table 9. Global Universal Nuclease Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Universal Nuclease Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Universal Nuclease Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Universal Nuclease, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Universal Nuclease, Product Type & Application Table 14. Global Universal Nuclease Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Universal Nuclease by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Merck Universal Nuclease Product Portfolio Table 22. Merck Recent Developments Table 23. Thermo Fisher Scientific Inc. Company Information Table 24. Thermo Fisher Scientific Inc. Business Overview Table 25. Thermo Fisher Scientific Inc. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolio Table 27. Thermo Fisher Scientific Inc. Recent Developments Table 28. New England Biolabs Company Information Table 29. New England Biolabs Business Overview Table 30. New England Biolabs Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. New England Biolabs Universal Nuclease Product Portfolio Table 32. New England Biolabs Recent Developments Table 33. Bio-Techne Corporation Company Information Table 34. Bio-Techne Corporation Business Overview Table 35. Bio-Techne Corporation Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Bio-Techne Corporation Universal Nuclease Product Portfolio Table 37. Bio-Techne Corporation Recent Developments Table 38. GenScript Company Information Table 39. GenScript Business Overview Table 40. GenScript Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. GenScript Universal Nuclease Product Portfolio Table 42. GenScript Recent Developments Table 43. AMSBIO Company Information Table 44. AMSBIO Business Overview Table 45. AMSBIO Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. AMSBIO Universal Nuclease Product Portfolio Table 47. AMSBIO Recent Developments Table 48. ACROBiosystems Group Company Information Table 49. ACROBiosystems Group Business Overview Table 50. ACROBiosystems Group Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. ACROBiosystems Group Universal Nuclease Product Portfolio Table 52. ACROBiosystems Group Recent Developments Table 53. Nanjing Vazyme Biotech Co., Ltd. Company Information Table 54. Nanjing Vazyme Biotech Co., Ltd. Business Overview Table 55. Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Product Portfolio Table 57. Nanjing Vazyme Biotech Co., Ltd. Recent Developments Table 58. Sino Biological,Inc. Company Information Table 59. Sino Biological,Inc. Business Overview Table 60. Sino Biological,Inc. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Sino Biological,Inc. Universal Nuclease Product Portfolio Table 62. Sino Biological,Inc. Recent Developments Table 63. ProteoGenix Company Information Table 64. ProteoGenix Business Overview Table 65. ProteoGenix Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. ProteoGenix Universal Nuclease Product Portfolio Table 67. ProteoGenix Recent Developments Table 68. Novoprotein Scientific Inc. Company Information Table 69. Novoprotein Scientific Inc. Business Overview Table 70. Novoprotein Scientific Inc. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Novoprotein Scientific Inc. Universal Nuclease Product Portfolio Table 72. Novoprotein Scientific Inc. Recent Developments Table 73. TransGen Biotech Company Information Table 74. TransGen Biotech Business Overview Table 75. TransGen Biotech Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. TransGen Biotech Universal Nuclease Product Portfolio Table 77. TransGen Biotech Recent Developments Table 78. Enzynomics Company Information Table 79. Enzynomics Business Overview Table 80. Enzynomics Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Enzynomics Universal Nuclease Product Portfolio Table 82. Enzynomics Recent Developments Table 83. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information Table 84. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview Table 85. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolio Table 87. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments Table 88. ProSpec Company Information Table 89. ProSpec Business Overview Table 90. ProSpec Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. ProSpec Universal Nuclease Product Portfolio Table 92. ProSpec Recent Developments Table 93. KACTUS Company Information Table 94. KACTUS Business Overview Table 95. KACTUS Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. KACTUS Universal Nuclease Product Portfolio Table 97. KACTUS Recent Developments Table 98. Shanghai Biyuntian Biotechnology Co., Ltd. Company Information Table 99. Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview Table 100. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 102. Shanghai Biyuntian Biotechnology Co., Ltd. Recent Developments Table 103. RayBiotech, Inc. Company Information Table 104. RayBiotech, Inc. Business Overview Table 105. RayBiotech, Inc. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. RayBiotech, Inc. Universal Nuclease Product Portfolio Table 107. RayBiotech, Inc. Recent Developments Table 108. Wuhan Hzymes Biotechnology Co., Ltd. Company Information Table 109. Wuhan Hzymes Biotechnology Co., Ltd. Business Overview Table 110. Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 112. Wuhan Hzymes Biotechnology Co., Ltd. Recent Developments Table 113. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Company Information Table 114. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Business Overview Table 115. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 117. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Recent Developments Table 118. Global Universal Nuclease Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Universal Nuclease Sales by Region (2021-2026) & (k units) Table 120. Global Universal Nuclease Sales Market Share by Region (2021-2026) Table 121. Global Universal Nuclease Sales by Region (2027-2032) & (k units) Table 122. Global Universal Nuclease Sales Market Share by Region (2027-2032) Table 123. Global Universal Nuclease Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Universal Nuclease Revenue Market Share by Region (2021-2026) Table 125. Global Universal Nuclease Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Universal Nuclease Revenue Market Share by Region (2027-2032) Table 127. North America Universal Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Universal Nuclease Sales by Country (2021-2026) & (k units) Table 129. North America Universal Nuclease Sales by Country (2027-2032) & (k units) Table 130. North America Universal Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Universal Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Universal Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Universal Nuclease Sales by Country (2021-2026) & (k units) Table 134. Europe Universal Nuclease Sales by Country (2027-2032) & (k units) Table 135. Europe Universal Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Universal Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Universal Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Universal Nuclease Sales by Country (2021-2026) & (k units) Table 139. Asia Pacific Universal Nuclease Sales by Country (2027-2032) & (k units) Table 140. Asia Pacific Universal Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Universal Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Universal Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Universal Nuclease Sales by Country (2021-2026) & (k units) Table 144. South America Universal Nuclease Sales by Country (2027-2032) & (k units) Table 145. South America Universal Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Universal Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Universal Nuclease Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Universal Nuclease Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Universal Nuclease Sales by Country (2027-2032) & (k units) Table 150. Middle East and Africa Universal Nuclease Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Universal Nuclease Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Universal Nuclease Sales by Type (2021-2026) & (k units) Table 153. Global Universal Nuclease Sales by Type (2027-2032) & (k units) Table 154. Global Universal Nuclease Sales Market Share by Type (2021-2026) Table 155. Global Universal Nuclease Sales Market Share by Type (2027-2032) Table 156. Global Universal Nuclease Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Universal Nuclease Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Universal Nuclease Revenue Market Share by Type (2021-2026) Table 159. Global Universal Nuclease Revenue Market Share by Type (2027-2032) Table 160. Global Universal Nuclease Price by Type (2021-2026) & (USD/unit) Table 161. Global Universal Nuclease Price by Type (2027-2032) & (USD/unit) Table 162. Global Universal Nuclease Sales by Application (2021-2026) & (k units) Table 163. Global Universal Nuclease Sales by Application (2027-2032) & (k units) Table 164. Global Universal Nuclease Sales Market Share by Application (2021-2026) Table 165. Global Universal Nuclease Sales Market Share by Application (2027-2032) Table 166. Global Universal Nuclease Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Universal Nuclease Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Universal Nuclease Revenue Market Share by Application (2021-2026) Table 169. Global Universal Nuclease Revenue Market Share by Application (2027-2032) Table 170. Global Universal Nuclease Price by Application (2021-2026) & (USD/unit) Table 171. Global Universal Nuclease Price by Application (2027-2032) & (USD/unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Universal Nuclease Distributors List Table 175. Universal Nuclease Customers List Table 176. Universal Nuclease Industry Trends Table 177. Universal Nuclease Industry Drivers Table 178. Universal Nuclease Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Universal Nuclease Product Image Figure 5. Global Universal Nuclease Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Universal Nuclease Market Size (2021-2032) & (US$ Million) Figure 7. Global Universal Nuclease Sales (2021-2032) & (k units) Figure 8. Global Universal Nuclease Average Price (USD/unit) & (2021-2032) Figure 9. GMP Product Image Figure 10. Scientific Research Product Image Figure 11. Medical Biology Product Image Figure 12. Laboratory Product Image Figure 13. Others Product Image Figure 14. Global Universal Nuclease Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Universal Nuclease, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Universal Nuclease Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Universal Nuclease Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Universal Nuclease Sales by Region in 2025 Figure 20. Global Universal Nuclease Revenue by Region in 2025 Figure 21. North America Universal Nuclease Market Size by Country in 2025 Figure 22. North America Universal Nuclease Sales Market Share by Country (2021-2032) Figure 23. North America Universal Nuclease Revenue Market Share by Country (2021-2032) Figure 24. United States Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Universal Nuclease Market Size by Country in 2025 Figure 28. Europe Universal Nuclease Sales Market Share by Country (2021-2032) Figure 29. Europe Universal Nuclease Revenue Market Share by Country (2021-2032) Figure 30. Germany Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Universal Nuclease Market Size by Country in 2025 Figure 41. Asia Pacific Universal Nuclease Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Universal Nuclease Revenue Market Share by Country (2021-2032) Figure 43. China Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Universal Nuclease Market Size by Country in 2025 Figure 52. South America Universal Nuclease Sales Market Share by Country (2021-2032) Figure 53. South America Universal Nuclease Revenue Market Share by Country (2021-2032) Figure 54. Brazil Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Universal Nuclease Market Size by Country in 2025 Figure 59. Middle East and Africa Universal Nuclease Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Universal Nuclease Revenue Market Share by Country (2021-2032) Figure 61. Egypt Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Universal Nuclease Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Universal Nuclease Sales Market Share by Type (2021-2032) Figure 67. Global Universal Nuclease Revenue Market Share by Type (2021-2032) Figure 68. Global Universal Nuclease Price (USD/unit) by Type (2021-2032) Figure 69. Global Universal Nuclease Sales Market Share by Application (2021-2032) Figure 70. Global Universal Nuclease Revenue Market Share by Application (2021-2032) Figure 71. Global Universal Nuclease Price (USD/unit) by Application (2021-2032) Figure 72. Universal Nuclease Value Chain Figure 73. Universal Nuclease Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Universal Nuclease Industry Opportunities and Challenges

Scope & coverage.

Types
  • GMP
  • Scientific Research
Applications
  • Medical Biology
  • Laboratory
  • Others
Companies covered
  • Merck
  • Thermo Fisher Scientific Inc.
  • New England Biolabs
  • Bio-Techne Corporation
  • GenScript
  • AMSBIO
  • ACROBiosystems Group
  • Nanjing Vazyme Biotech Co., Ltd.
  • Sino Biological,Inc.
  • ProteoGenix
  • Novoprotein Scientific Inc.
  • TransGen Biotech
  • Enzynomics
  • Yisheng Biotechnology (Shanghai) Co., Ltd.
  • ProSpec
  • KACTUS
  • Shanghai Biyuntian Biotechnology Co., Ltd.
  • RayBiotech, Inc.
  • Wuhan Hzymes Biotechnology Co., Ltd.
  • Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Universal Nuclease Market Size (2021-2032)
  4. 2.2.2 Global Universal Nuclease Sales (2021-2032)
  5. 2.2.3 Global Universal Nuclease Market Average Price (2021-2032)
  6. 2.3 Universal Nuclease by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 GMP
  9. 2.3.3 Scientific Research
  10. 2.4 Universal Nuclease by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Medical Biology
  13. 2.4.3 Laboratory
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Universal Nuclease Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Universal Nuclease Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Universal Nuclease Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Universal Nuclease Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Universal Nuclease Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Universal Nuclease, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Universal Nuclease, Product Type & Application
  8. 3.8 Global Manufacturers of Universal Nuclease, Established Date
  9. 3.9 Global Universal Nuclease Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Universal Nuclease Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Thermo Fisher Scientific Inc.
  8. 4.2.1 Thermo Fisher Scientific Inc. Company Information
  9. 4.2.2 Thermo Fisher Scientific Inc. Business Overview
  10. 4.2.3 Thermo Fisher Scientific Inc. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolio
  12. 4.2.5 Thermo Fisher Scientific Inc. Recent Developments
  13. 4.3 New England Biolabs
  14. 4.3.1 New England Biolabs Company Information
  15. 4.3.2 New England Biolabs Business Overview
  16. 4.3.3 New England Biolabs Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 New England Biolabs Universal Nuclease Product Portfolio
  18. 4.3.5 New England Biolabs Recent Developments
  19. 4.4 Bio-Techne Corporation
  20. 4.4.1 Bio-Techne Corporation Company Information
  21. 4.4.2 Bio-Techne Corporation Business Overview
  22. 4.4.3 Bio-Techne Corporation Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bio-Techne Corporation Universal Nuclease Product Portfolio
  24. 4.4.5 Bio-Techne Corporation Recent Developments
  25. 4.5 GenScript
  26. 4.5.1 GenScript Company Information
  27. 4.5.2 GenScript Business Overview
  28. 4.5.3 GenScript Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 GenScript Universal Nuclease Product Portfolio
  30. 4.5.5 GenScript Recent Developments
  31. 4.6 AMSBIO
  32. 4.6.1 AMSBIO Company Information
  33. 4.6.2 AMSBIO Business Overview
  34. 4.6.3 AMSBIO Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AMSBIO Universal Nuclease Product Portfolio
  36. 4.6.5 AMSBIO Recent Developments
  37. 4.7 ACROBiosystems Group
  38. 4.7.1 ACROBiosystems Group Company Information
  39. 4.7.2 ACROBiosystems Group Business Overview
  40. 4.7.3 ACROBiosystems Group Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 ACROBiosystems Group Universal Nuclease Product Portfolio
  42. 4.7.5 ACROBiosystems Group Recent Developments
  43. 4.8 Nanjing Vazyme Biotech Co., Ltd.
  44. 4.8.1 Nanjing Vazyme Biotech Co., Ltd. Company Information
  45. 4.8.2 Nanjing Vazyme Biotech Co., Ltd. Business Overview
  46. 4.8.3 Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Product Portfolio
  48. 4.8.5 Nanjing Vazyme Biotech Co., Ltd. Recent Developments
  49. 4.9 Sino Biological,Inc.
  50. 4.9.1 Sino Biological,Inc. Company Information
  51. 4.9.2 Sino Biological,Inc. Business Overview
  52. 4.9.3 Sino Biological,Inc. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sino Biological,Inc. Universal Nuclease Product Portfolio
  54. 4.9.5 Sino Biological,Inc. Recent Developments
  55. 4.10 ProteoGenix
  56. 4.10.1 ProteoGenix Company Information
  57. 4.10.2 ProteoGenix Business Overview
  58. 4.10.3 ProteoGenix Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 ProteoGenix Universal Nuclease Product Portfolio
  60. 4.10.5 ProteoGenix Recent Developments
  61. 4.11 Novoprotein Scientific Inc.
  62. 4.11.1 Novoprotein Scientific Inc. Company Information
  63. 4.11.2 Novoprotein Scientific Inc. Business Overview
  64. 4.11.3 Novoprotein Scientific Inc. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Novoprotein Scientific Inc. Universal Nuclease Product Portfolio
  66. 4.11.5 Novoprotein Scientific Inc. Recent Developments
  67. 4.12 TransGen Biotech
  68. 4.12.1 TransGen Biotech Company Information
  69. 4.12.2 TransGen Biotech Business Overview
  70. 4.12.3 TransGen Biotech Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 TransGen Biotech Universal Nuclease Product Portfolio
  72. 4.12.5 TransGen Biotech Recent Developments
  73. 4.13 Enzynomics
  74. 4.13.1 Enzynomics Company Information
  75. 4.13.2 Enzynomics Business Overview
  76. 4.13.3 Enzynomics Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Enzynomics Universal Nuclease Product Portfolio
  78. 4.13.5 Enzynomics Recent Developments
  79. 4.14 Yisheng Biotechnology (Shanghai) Co., Ltd.
  80. 4.14.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
  81. 4.14.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
  82. 4.14.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolio
  84. 4.14.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments
  85. 4.15 ProSpec
  86. 4.15.1 ProSpec Company Information
  87. 4.15.2 ProSpec Business Overview
  88. 4.15.3 ProSpec Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 ProSpec Universal Nuclease Product Portfolio
  90. 4.15.5 ProSpec Recent Developments
  91. 4.16 KACTUS
  92. 4.16.1 KACTUS Company Information
  93. 4.16.2 KACTUS Business Overview
  94. 4.16.3 KACTUS Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 KACTUS Universal Nuclease Product Portfolio
  96. 4.16.5 KACTUS Recent Developments
  97. 4.17 Shanghai Biyuntian Biotechnology Co., Ltd.
  98. 4.17.1 Shanghai Biyuntian Biotechnology Co., Ltd. Company Information
  99. 4.17.2 Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview
  100. 4.17.3 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  102. 4.17.5 Shanghai Biyuntian Biotechnology Co., Ltd. Recent Developments
  103. 4.18 RayBiotech, Inc.
  104. 4.18.1 RayBiotech, Inc. Company Information
  105. 4.18.2 RayBiotech, Inc. Business Overview
  106. 4.18.3 RayBiotech, Inc. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 RayBiotech, Inc. Universal Nuclease Product Portfolio
  108. 4.18.5 RayBiotech, Inc. Recent Developments
  109. 4.19 Wuhan Hzymes Biotechnology Co., Ltd.
  110. 4.19.1 Wuhan Hzymes Biotechnology Co., Ltd. Company Information
  111. 4.19.2 Wuhan Hzymes Biotechnology Co., Ltd. Business Overview
  112. 4.19.3 Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  114. 4.19.5 Wuhan Hzymes Biotechnology Co., Ltd. Recent Developments
  115. 4.20 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.
  116. 4.20.1 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Company Information
  117. 4.20.2 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Business Overview
  118. 4.20.3 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  120. 4.20.5 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Recent Developments
5 Global Universal Nuclease Market Scenario by Region
  1. 5.1 Global Universal Nuclease Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Universal Nuclease Sales by Region: 2021-2032
  3. 5.2.1 Global Universal Nuclease Sales by Region: 2021-2026
  4. 5.2.2 Global Universal Nuclease Sales by Region: 2027-2032
  5. 5.3 Global Universal Nuclease Revenue by Region: 2021-2032
  6. 5.3.1 Global Universal Nuclease Revenue by Region: 2021-2026
  7. 5.3.2 Global Universal Nuclease Revenue by Region: 2027-2032
  8. 5.4 North America Universal Nuclease Market Facts & Figures by Country
  9. 5.4.1 North America Universal Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Universal Nuclease Sales by Country (2021-2032)
  11. 5.4.3 North America Universal Nuclease Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Universal Nuclease Market Facts & Figures by Country
  16. 5.5.1 Europe Universal Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Universal Nuclease Sales by Country (2021-2032)
  18. 5.5.3 Europe Universal Nuclease Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Universal Nuclease Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Universal Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Universal Nuclease Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Universal Nuclease Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Universal Nuclease Market Facts & Figures by Country
  41. 5.7.1 South America Universal Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Universal Nuclease Sales by Country (2021-2032)
  43. 5.7.3 South America Universal Nuclease Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Universal Nuclease Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Universal Nuclease Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Universal Nuclease Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Universal Nuclease Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Universal Nuclease Sales by Type (2021-2032)
  2. 6.1.1 Global Universal Nuclease Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Universal Nuclease Sales Market Share by Type (2021-2032)
  4. 6.2 Global Universal Nuclease Revenue by Type (2021-2032)
  5. 6.2.1 Global Universal Nuclease Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Universal Nuclease Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Universal Nuclease Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Universal Nuclease Sales by Application (2021-2032)
  2. 7.1.1 Global Universal Nuclease Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Universal Nuclease Sales Market Share by Application (2021-2032)
  4. 7.2 Global Universal Nuclease Revenue by Application (2021-2032)
  5. 7.2.1 Global Universal Nuclease Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Universal Nuclease Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Universal Nuclease Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Universal Nuclease Value Chain Analysis
  2. 8.1.1 Universal Nuclease Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Universal Nuclease Production Mode & Process
  5. 8.2 Universal Nuclease Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Universal Nuclease Distributors
  8. 8.2.3 Universal Nuclease Customers
9 Global Universal Nuclease Analyzing Market Dynamics
  1. 9.1 Universal Nuclease Industry Trends
  2. 9.2 Universal Nuclease Industry Drivers
  3. 9.3 Universal Nuclease Industry Opportunities and Challenges
  4. 9.4 Universal Nuclease Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst